Chronic-Progressive Dopaminergic Deficiency Does Not Induce Midbrain Neurogenesis

Area of Science:

• Neuroscience
• Stem Cell Biology
• Neurodegenerative Diseases

Background:

• Adult neurogenesis occurs in the ventricular-subventricular zone (V-SVZ) and is debated in other brain regions.
• Dopamine influences neural stem cell (aNSC) proliferation, but its role in mid/hindbrain PVRs during neurodegeneration is unclear.

Purpose of the Study:

• To investigate how chronic dopaminergic neurodegeneration affects neurogenesis in the V-SVZ and mid/hindbrain aNSCs.
• To analyze these effects in two distinct transgenic mouse models of Parkinson's disease (PD).

Main Methods:

• Utilized Thy1-m[A30P]h α synuclein and Leu9'Ser hypersensitive α4* nAChR transgenic mouse models of PD.
• Assessed neurogenic activity in the V-SVZ, aqueduct, and fourth ventricle PVRs following midbrain dopaminergic neuronal loss.

Main Results:

• Overall proliferation in the V-SVZ remained unchanged in both models.
• A reduced proportion of specific proliferating cells (B2/activated B1) was observed in the V-SVZ of Leu9'Ser hypersensitive α4* nAChR mice.
• Dopaminergic deficiency did not induce proliferation in quiescent mid/hindbrain PVR aNSCs.

Conclusions:

• The study found no evidence of adult neural stem cell activation in mid/hindbrain PVRs following dopaminergic neurodegeneration.
• These findings indicate that spontaneous endogenous regeneration of lost dopaminergic neurons by resident aNSCs is improbable.